Introduction. People with rheumatic disease are at increased risk of infection due to immune dysregulation and the use of immunosuppressive medications.1, 2 Behavioural changes that could mitigate these risks are often discussed as part of the shared decision making that occurs during the management of rheumatic diseases. 3 However, at the beginning of the COVID-19 pandemic, little was known ....